tirzepatide injections phoenixville Zepbound Tirzepatide Injection 10 mg/0.5 mL glp-1 weight loss phoenixville Program

If you have suffered from severe gastrointestinal issues as a result of Ozempic, Shreveport injury attorney Joey Greenwald is here to help

The opportunity to experience long-term results makes this treatment highly valuable

N Engl J Med (2016) 375:31122

Tirzepatide was officially approved as a weight loss drug by the FDA in 2023, and since then, its popularity as a weight loss treatment has skyrocketed

GLP-1 receptor activation slows gastric emptying, which can cause both diarrhoea and constipation depending on the individual

Its very common to do that even without a specific FDA approval indication. While we await the results of these trials, we also need to contend with some hard truths